Gabelli Funds Maintains Holding in Nutri Sys New Com (NTRI); Barclays Plc Has Decreased Its Stake in Seattle Genetics (Put) (SGEN) by $2.03 Million as Share Value Rose

Seattle Genetics, Inc. (NASDAQ:SGEN) Logo

Barclays Plc decreased its stake in Seattle Genetics Inc (Put) (SGEN) by 91.18% based on its latest 2018Q4 regulatory filing with the SEC. Barclays Plc sold 36,200 shares as the company’s stock rose 17.34% with the market. The institutional investor held 3,500 shares of the health care company at the end of 2018Q4, valued at $198,000, down from 39,700 at the end of the previous reported quarter. Barclays Plc who had been investing in Seattle Genetics Inc (Put) for a number of months, seems to be less bullish one the $11.98B market cap company. The stock increased 1.39% or $1.02 during the last trading session, reaching $74.62. About 995,287 shares traded or 19.58% up from the average. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 37.73% since March 17, 2018 and is uptrending. It has outperformed by 33.36% the S&P500. Some Historical SGEN News: 20/03/2018 – SEATTLE GENETICS INC – FDA ALSO GRANTED PRIORITY REVIEW FOR SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR ADCETRIS; 15/03/2018 – Seattle Genetics Appoints Dr. Alpna Seth to Bd of Directors; 20/03/2018 – SEATTLE GENETICS INC – PRESCRIPTION DRUG USER FEE ACT TARGET ACTION DATE MAY 1, 2018; 26/03/2018 – Astellas and Seattle Genetics Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metast; 16/04/2018 – CELLDEX THERAPEUTICS INC – NO SIGNIFICANT ADVANTAGE FOR GLEMBATUMUMAB VEDOTIN IN KEY SECONDARY ENDPOINTS; 26/04/2018 – Seattle Genetics Had Seen 2018 R&D Costs $460M-$500M; 26/04/2018 – SEATTLE GENETICS WITHDRAWS 2018 ADCETRIS SALES; 17/05/2018 – Seattle Genetics Presenting at Conference Jun 3; 07/03/2018 Report: Developing Opportunities within Seattle Genetics, PBF Energy, Chipotle Mexican Grill, CIT Group Inc (DEL), PDL BioPharm; 02/05/2018 – Seattle Genetics at Bank of America Conference May 16

Gabelli Funds Llc increased its stake in Nutri Sys Inc New Com (NTRI) by 484.4% based on its latest 2018Q4 regulatory filing with the SEC. Gabelli Funds Llc bought 121,100 shares as the company’s stock rose 16.42% with the market. The institutional investor held 146,100 shares of the catalog and specialty distribution company at the end of 2018Q4, valued at $6.41M, up from 25,000 at the end of the previous reported quarter. Gabelli Funds Llc who had been investing in Nutri Sys Inc New Com for a number of months, seems to be bullish on the $1.26B market cap company. It closed at $42.89 lastly. It is down 39.55% since March 17, 2018 and is uptrending. It has outperformed by 35.18% the S&P500. Some Historical NTRI News: 07/05/2018 – Nutrisystem, Inc. Sponsors the American Heart Association Go Red for Women Campaign in Greater Philadelphia; 23/04/2018 – EY Announces Dawn Zier, CEO of Nutrisystem, Inc., Entrepreneur Of The Year® 2018 Award Finalist in Greater Philadelphia; 30/04/2018 – Nutrisystem Sees 2Q EPS 78c-EPS 83c; 17/05/2018 – Nutrisystem Presenting at Conference May 30; 30/04/2018 – Nutrisystem Raises FY View To Rev $693M-$708M; 30/04/2018 – Nutrisystem Sees FY Net $61.8M-Net $64.8M; 30/04/2018 – NUTRISYSTEM 1Q REV. $210.9M, EST. $207.0M; 22/05/2018 – Nutrisystem Presenting at Conference Tomorrow; 04/04/2018 South Beach Diet® Expands Snack Line Adding a Dozen New Low-Sugar, Low-Carb Items to Its Menu; 30/04/2018 – NUTRISYSTEM SEES 2Q EPS 78C TO 83C, EST. 88C

Investors sentiment decreased to 0.92 in Q4 2018. Its down 0.21, from 1.13 in 2018Q3. It dived, as 35 investors sold NTRI shares while 61 reduced holdings. 44 funds opened positions while 44 raised stakes. 26.60 million shares or 9.77% less from 29.48 million shares in 2018Q3 were reported. Moreover, Raymond James & Associate has 0.01% invested in Nutrisystem, Inc. (NASDAQ:NTRI). First Advsr LP holds 0% in Nutrisystem, Inc. (NASDAQ:NTRI) or 26,386 shares. Highland Capital Mngmt LP reported 0.12% in Nutrisystem, Inc. (NASDAQ:NTRI). Huntington Fincl Bank has 948 shares for 0% of their portfolio. Nordea Investment Management Ab stated it has 0.02% of its portfolio in Nutrisystem, Inc. (NASDAQ:NTRI). Voya Inv Management Lc accumulated 12,388 shares. National Bank Of America Corporation De owns 136,162 shares. Charles Schwab Mgmt holds 0.01% of its portfolio in Nutrisystem, Inc. (NASDAQ:NTRI) for 161,952 shares. Royal Financial Bank Of Canada has 1,198 shares. Water Island Cap Ltd reported 1.24% in Nutrisystem, Inc. (NASDAQ:NTRI). Cubist Systematic Strategies Llc invested 0.01% in Nutrisystem, Inc. (NASDAQ:NTRI). Stevens Capital Management LP holds 0.06% of its portfolio in Nutrisystem, Inc. (NASDAQ:NTRI) for 25,900 shares. Ameriprise invested 0% of its portfolio in Nutrisystem, Inc. (NASDAQ:NTRI). 200,000 are owned by Caisse De Depot Et Placement Du Quebec. Assetmark Incorporated holds 0% or 134 shares in its portfolio.

Gabelli Funds Llc, which manages about $25.90B and $14.58 billion US Long portfolio, decreased its stake in Conocophillips Com (NYSE:COP) by 10,000 shares to 528,172 shares, valued at $32.93 million in 2018Q4, according to the filing. It also reduced its holding in Sony Corp (NYSE:SNE) by 81,300 shares in the quarter, leaving it with 2.62 million shares, and cut its stake in El Paso Elec Co Com New (NYSE:EE).

More notable recent Nutrisystem, Inc. (NASDAQ:NTRI) news were published by: Seekingalpha.com which released: “Moving From Buy To Hold On Nutrisystems – Seeking Alpha” on June 04, 2018, also Seekingalpha.com with their article: “Nutrisystem: Personalized Nutrition On Rise – Seeking Alpha” published on October 14, 2018, Seekingalpha.com published: “Nutrisystem +7.2% post Q3 results – Seeking Alpha” on October 31, 2018. More interesting news about Nutrisystem, Inc. (NASDAQ:NTRI) were released by: Seekingalpha.com and their article: “WRE +5.8%, CSII +7% on moves into SmallCap 600 – Seeking Alpha” published on March 01, 2019 as well as Seekingalpha.com‘s news article titled: “Investors size up Tivity Health-Nutrisystem deal – Seeking Alpha” with publication date: December 10, 2018.

Barclays Plc, which manages about $129.47B US Long portfolio, upped its stake in Gopro Inc (NASDAQ:GPRO) by 1.49M shares to 1.66 million shares, valued at $7.02 million in 2018Q4, according to the filing. It also increased its holding in Gap Inc Del (NYSE:GPS) by 723,310 shares in the quarter, for a total of 888,910 shares, and has risen its stake in Colgate Palmolive Co (Call) (NYSE:CL).

More notable recent Seattle Genetics, Inc. (NASDAQ:SGEN) news were published by: Nasdaq.com which released: “SGEN April 18th Options Begin Trading – Nasdaq” on February 12, 2019, also Nasdaq.com with their article: “Seattle Genetics (SGEN) Down 6.1% Since Last Earnings Report: Can It Rebound? – Nasdaq” published on March 09, 2019, Nasdaq.com published: “Look Under The Hood: PBUS Has 10% Upside – Nasdaq” on March 07, 2019. More interesting news about Seattle Genetics, Inc. (NASDAQ:SGEN) were released by: Gurufocus.com and their article: “Mar 06, 2019 – ImmunoGen Failure Casts a Shadow on Antibody-Drug Conjugates – GuruFocus.com” published on March 06, 2019 as well as Seekingalpha.com‘s news article titled: “Seattle Genetics Q3 top line up 25% – Seeking Alpha” with publication date: October 25, 2018.

Analysts await Seattle Genetics, Inc. (NASDAQ:SGEN) to report earnings on April, 25. They expect $-0.28 earnings per share, up 54.10% or $0.33 from last year’s $-0.61 per share. After $-0.57 actual earnings per share reported by Seattle Genetics, Inc. for the previous quarter, Wall Street now forecasts -50.88% EPS growth.

Since September 17, 2018, it had 0 insider buys, and 10 sales for $9.27 million activity. GRYSKA DAVID W sold $325,200 worth of stock. On Wednesday, November 21 Cline Darren S sold $236,204 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) or 4,167 shares. $310,718 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) was sold by HIMES VAUGHN B on Friday, November 30.

Seattle Genetics, Inc. (NASDAQ:SGEN) Institutional Positions Chart